| All OR (95% CI) | Men OR (95% CI) | Women OR (95% CI) |
---|
Adverse events | Na(nb) | Crudec | Adjustedd | Na (nb) | Crudec | Adjustede, f | Na(nb) | Crudec | Adjustedg |
---|
No (NRS < 1) | 176 (93) | 1.0 (ref.) | 1.0 (ref.) | 73 (34) | 1.0 (ref.) | 1.0 (ref.) | 103 (59) | 1.0 (ref.) | 1.0 (ref.) |
Mild (NRS 1–3) | 384 (210) | 1.08 (0.75–1.54) | 1.19 (0.82–1.72) | 112 (67) | 1.72 (0.95–1.12) | 2.44 (1.24–4.80) | 272 (143) | 0.83 (0.53–1.91) | 0.84 (0.55–1.40) |
Moderate/major (NRS ≥ 4) | 180 (77) | 0.67 (0.44–1.01) | 0.76 (0.50–1.18) | 33 (12) | 0.66 (0.28–1.55) | 0.58 (0.22–1.52) | 147 (65) | 0.60 (0.34–0.99) | 0.68 (0.40–1.13) |
- Abbreviations: AE, adverse events; OR, Odds Ratio; CI, confidence interval; NRS, numeric rating scale (0–10)
- aNumber of patient in AE group
- bNumber of recovered patient measured by perceived recovery in AE group
- cTreatment arm included in analysis
- dAdjusted for treatment arm and recovery expectations
- eMild AE; Adjusted for treatment arm, recovery expectations and pain location
- fModerate AE; Adjusted for treatment arm and recovery expectations, distress, disability at baseline and pain duration
- gAdjusted for treatment arm and pain at baseline (confounder for women regarding moderate AE)